54: Bullous Pemphigoid Flashcards

1
Q

What is bullous pemphigoid and how does it typically present in patients?

A

Bullous pemphigoid is the most common autoimmune blistering disorder in adults, typically presenting as pruritic, tense blisters often on a background of urticarial plaques. It occurs most frequently in older adults and is characterized by large, tense blisters arising on normal skin or on an erythematous or urticarial base.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the common clinical features and findings associated with bullous pemphigoid?

A

The classic form of bullous pemphigoid is characterized by large, tense blisters on normal or erythematous skin, most commonly found on flexural surfaces, lower abdomen, and thighs. It features negative Nikolsky and Asboe-Hansen signs, intense pruritus, and nonbullous lesions may be the first manifestation in almost half of patients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the epidemiology of bullous pemphigoid regarding age and incidence?

A

Bullous pemphigoid typically occurs in patients older than 60 years of age, with a peak incidence in the 70s. There is no known ethnic, racial, or sexual predilection associated with the condition.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the complications associated with bullous pemphigoid?

A

Complications may include skin infections developing within denuded bullae, dehydration, electrolyte imbalance, possible death from sepsis, and complications caused by bacterial and viral infections.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What diagnostic methods are used to confirm bullous pemphigoid?

A

Diagnosis of bullous pemphigoid is confirmed by routine histology, direct immunofluorescence (IF), indirect IF, or enzyme-linked immunosorbent assay (ELISA).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the typical clinical features of bullous pemphigoid in older adults?

A

Bullous pemphigoid typically presents as large, tense blisters on normal skin or an erythematous/urticarial base, most commonly found on flexural surfaces, lower abdomen, and thighs. Pruritus is usually intense but can be minimal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Discuss the immunological mechanisms involved in the pathogenesis of bullous pemphigoid.

A

Bullous pemphigoid is characterized by autoantibodies directed against hemidesmosomal proteins BP180 and BP230, triggering an inflammatory cascade leading to blister formation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the potential complications associated with bullous pemphigoid?

A

Complications include skin infections, dehydration, electrolyte imbalance, and possibly death from sepsis, necessitating careful monitoring and management strategies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the most likely diagnosis for a 70-year-old patient with large, tense blisters?

A

The most likely diagnosis is bullous pemphigoid. Diagnostic tests include routine histology, direct immunofluorescence (IF), indirect IF, or enzyme-linked immunosorbent assay (ELISA).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What could be the precipitating factor for localized tense bullae in a patient with a history of radiation therapy?

A

The localized bullous pemphigoid could be precipitated by changes induced by radiation therapy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is lichen planus pemphigoides?

A

This condition typically affects middle-aged patients and is more localized to the extremities with a less severe clinical course.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the role of the Bullous Pemphigoid Disease Area Index (BPDAI) in clinical practice?

A

The BPDAI is a validated tool used to objectively measure clinical disease activity in patients with bullous pemphigoid.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What percentage of patients with bullous pemphigoid exhibit elevated serum IgE levels and peripheral blood eosinophilia?

A

Approximately 75% of patients have elevated serum IgE levels, and more than half have peripheral blood eosinophilia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What triggers the inflammatory cascade that results in blister formation in bullous pemphigoid?

A

Autoantibody binding to hemidesmosomal antigens triggers an inflammatory cascade that ultimately results in blister formation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the two distinct antigens recognized by bullous pemphigoid autoantibodies?

A

Bullous pemphigoid autoantibodies recognize two distinct antigens with molecular weights of 230 kDa (BP230) and 180 kDa (BP180).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the predominant cell type found in the inflammatory infiltrate of bullous pemphigoid?

A

The predominant cell type found in the inflammatory infiltrate of bullous pemphigoid is eosinophils.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What role do IgG antibodies play in the pathogenesis of bullous pemphigoid?

A

IgG antibodies generate dermal–epidermal separation in the presence of complement and leukocytes, contributing to the pathogenesis of bullous pemphigoid.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are some risk factors associated with bullous pemphigoid?

A

Risk factors include HLA-DQB1*0301 associated with classic bullous pemphigoid, certain HLA alleles in Japanese patients, and neurological diseases increasing the risk of developing BP.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are the key immunopathological mechanisms involved in the formation of blisters in bullous pemphigoid?

A

The formation of blisters is primarily due to autoantibody binding, inflammatory cell infiltration, proteolytic activity, and recruitment of inflammatory cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

How do BP180 and BP230 contribute to the pathophysiology of bullous pemphigoid?

A

BP180 is involved in anchoring the epidermis to the dermis, while BP230 stabilizes the cytoskeleton of basal cells. Autoantibodies against both trigger inflammatory responses leading to blister formation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What role do risk factors such as HLA alleles play in the development of bullous pemphigoid?

A

Risk factors include HLA-DQB1*0301 associated with classic bullous pemphigoid, and specific HLA alleles linked to increased risk in Japanese patients.

22
Q

What are the clinical implications of the presence of autoantibodies against BP180 and BP230?

A

Detection of these autoantibodies is crucial for diagnosis, correlating with disease severity and treatment response.

23
Q

What are the potential triggers for bullous pemphigoid?

A

Potential triggers include ultraviolet light, radiation therapy, and certain medications.

24
Q

What are the two main antigens targeted by autoantibodies in bullous pemphigoid?

A

The two main antigens are BP230 (BPAG1) and BP180 (BPAG2), located in the hemidesmosome and the basement membrane, respectively.

25
Describe the role of the NC16A domain in the pathogenesis of bullous pemphigoid.
The NC16A domain of BP180 harbors major autoantibody-reactive epitopes and triggers the inflammatory cascade leading to tissue injury and blister formation.
26
How do IgG and IgE autoantibodies contribute to the pathogenesis of bullous pemphigoid?
IgG autoantibodies generate dermal-epidermal separation, while IgE autoantibodies activate mast cells and recruit eosinophils.
27
What genetic factors are associated with an increased risk of bullous pemphigoid?
HLA-DQB1*0301 is associated with classic bullous pemphigoid in whites, while specific HLA alleles increase risk in Japanese patients.
28
What is the relationship between neurological diseases and bullous pemphigoid?
Patients with neurological diseases, including dementia, stroke, and Parkinson's disease, have a significantly higher risk of developing bullous pemphigoid.
29
What histological findings are characteristic of bullous pemphigoid?
Histological findings include subepidermal blisters with a superficial dermal infiltrate consisting of eosinophils, neutrophils, lymphocytes, monocytes, and macrophages.
30
What is the significance of indirect immunofluorescence (IF) antibody titers in bullous pemphigoid?
Indirect IF antibody titers do not usually correlate with disease extent or activity, indicating they may not be reliable indicators of disease severity.
31
How can epidermolysis bullosa acquisita (EBA) be distinguished from bullous pemphigoid?
EBA can usually be distinguished by indirect or direct immunofluorescence on salt split skin, where the binding patterns of antibodies differ.
32
What factors are associated with a poor prognosis in bullous pemphigoid?
Factors include old age, poor general health, neurologic disease, extensive disease, and the presence of anti-BP180 antibodies.
33
What is the mainstay treatment for extensive bullous pemphigoid?
The mainstay treatment for extensive bullous pemphigoid is oral prednisone, while localized cases can often be treated with topical corticosteroids.
34
What is the relationship between ELISA titers and the risk of relapse in bullous pemphigoid?
High ELISA titers and positive direct immunofluorescence at the time of therapy cessation are associated with a high risk of relapse.
35
What are the key differences in immunofluorescence findings between bullous pemphigoid and epidermolysis bullosa acquisita (EBA)?
In bullous pemphigoid, antibodies bind the epidermal side of the blister, while in EBA, antibodies bind the dermal side.
36
How can cicatricial pemphigoid be differentiated from bullous pemphigoid based on clinical presentation?
Cicatricial pemphigoid primarily presents with mucosal lesions and scarring, while bullous pemphigoid is characterized by large, tense blisters.
37
What factors are associated with a poor prognosis in patients with bullous pemphigoid?
Factors include old age, poor general health, neurologic disease, extensive disease, and presence of anti-BP180 antibodies.
38
What is the recommended management approach for localized versus extensive bullous pemphigoid?
Localized bullous pemphigoid can often be treated successfully with topical corticosteroids alone.
39
What factors are associated with a poor prognosis in patients with bullous pemphigoid?
Factors include old age, poor general health, neurologic disease, extensive disease, and the presence of anti-BP180 antibodies.
40
What is the recommended management approach for localized versus extensive bullous pemphigoid?
Localized bullous pemphigoid can often be treated successfully with topical corticosteroids alone. Extensive disease typically requires treatment with oral prednisone.
41
How does immunofluorescence help differentiate bullous pemphigoid from epidermolysis bullosa acquisita (EBA)?
In salt-split skin, bullous pemphigoid antibodies bind the epidermal side of the blister, while EBA antibodies bind the dermal side.
42
What is the significance of antigen-specific IgE antibodies in bullous pemphigoid?
Antigen-specific IgE antibodies may correlate with disease severity and play a role in recruiting eosinophils to skin lesions.
43
What percentage of the normal population has anti-BP180 antibodies detectable by ELISA without clinical or histologic features of bullous pemphigoid?
7% of the normal population has anti-BP180 antibodies detectable by ELISA without clinical or histologic features of the disease.
44
How does cicatricial pemphigoid differ from bullous pemphigoid in terms of clinical presentation?
Cicatricial pemphigoid predominantly presents with mucosal lesions, desquamative gingivitis, and conjunctival inflammation and scarring, whereas large, tense blisters are characteristic of bullous pemphigoid.
45
What is the recommended treatment for localized bullous pemphigoid?
Localized bullous pemphigoid can often be treated successfully with topical corticosteroids alone.
46
What is the mainstay of treatment for more extensive bullous pemphigoid?
Oral prednisone remains the mainstay of treatment for more extensive bullous pemphigoid.
47
What are the recommended treatments for bullous pemphigoid?
The treatments for bullous pemphigoid include high-potency topical steroids, prednisone, azathioprine, mycophenolate mofetil, methotrexate, intravenous gammaglobulin, plasmapheresis, dapsone, sulfapyridine, tetracycline or erythromycin, omalizumab, and rituximab.
48
What is the recommended tapering regimen for prednisone after the consolidation phase in bullous pemphigoid treatment?
The recommended tapering regimen for prednisone after the consolidation phase is to start with a dose of 30 mg, lower the dose by 5 mg weekly until reaching 30 mg, and then initiate an alternating-day tapering regimen.
49
What is the role of dapsone and sulfapyridine in the treatment of bullous pemphigoid?
Dapsone and sulfapyridine have been reported to control disease activity in approximately 15% to 44% of patients with bullous pemphigoid.
50
What steroid-sparing agents are commonly used in conjunction with prednisone for bullous pemphigoid?
Steroid-sparing agents include methotrexate, azathioprine, and mycophenolate mofetil.
51
What is the role of clobetasol propionate cream in the management of bullous pemphigoid?
Clobetasol propionate cream 0.05% applied twice daily is effective in both moderate and severe bullous pemphigoid and may be safer than oral prednisone.
52
What are the starting doses of prednisone for treating bullous pemphigoid?
Starting doses of prednisone range from 0.75 to 1.0 mg/kg/day.